Interspecies metabolic diversity of artocarpin in vitro mammalian liver microsomes

References

• Septama AW, Panichayupakaranant P. Synergistic effect of artocarpin on antibacterial activity of some antibiotics against methicillin-resistant Staphylococcus aureus, Pseudomonas aeruginosa, and Escherichia coli. Pharm Biol. 2016;54:686–691.
   PubMed Web of Science ®Google Scholar
• Septama AW, Jantan I, Panichayupakaranant P. Flavonoids of Artocarpus heterophyllus Lam. heartwood inhibit the innate immune responses of human phagocytes. J Pharm Pharmacol. 2018;70:1242–1252.
   PubMed Web of Science ®Google Scholar
• Lee CW, Hsu LF, Lee MH, et al. Extracts of artocarpus communis induce mitochondria-associated apoptosis via pro-oxidative activity in human glioblastoma cells. Front Pharmacol. 2018;9:411.
   PubMed Web of Science ®Google Scholar
• Sun G, Zheng Z, Lee MH, et al. Chemoprevention of colorectal cancer by artocarpin, a dietary phytochemical from Artocarpus heterophyllus. J Agric Food Chem. 2017;65:3474–3480.
   PubMed Web of Science ®Google Scholar
• Tsai MH, Liu JF, Chiang YC, et al. Artocarpin, an isoprenyl flavonoid, induces p53-dependent or independent apoptosis via ROS-mediated MAPKs and Akt activation in non-small cell lung cancer cells. Oncotarget. 2017;8:28342–28358.
   PubMed Web of Science ®Google Scholar
• Lee CW, Chi MC, Chang TM, et al. Artocarpin induces cell apoptosis in human osteosarcoma cells through endoplasmic reticulum stress and reactive oxygen species. J Cell Physiol. 2019;234:13157–13168.
   PubMed Web of Science ®Google Scholar
• Qu W, Liu X. Identification of cytochrome P450 isoforms involved in the metabolism of artocarpin and assessment of its drug-drug interaction. Biomed Chromatogr. 2018;32:e4149.
   Web of Science ®Google Scholar
• Kishino Y, Hasegawa T, Yamoto T, et al. Species differences in micronucleus induction of the clastogenic compounds associated with drug metabolic profile. J Toxicol Sci. 2019;44:701–709.
   PubMed Web of Science ®Google Scholar
• Nishimuta H, Nakagawa T, Nomura N, et al. Species differences in hepatic and intestinal metabolic activities for 43 human cytochrome P450 substrates between humans and rats or dogs. Xenobiotica. 2013;43:948–955.
   PubMed Web of Science ®Google Scholar
• Smith PK, Krohn RI, Hermanson GT, et al. Measurement of protein using bicinchoninic acid. Anal Biochem. 1985;150:76–85.
   PubMed Web of Science ®Google Scholar
• Shi X, Yang S, Zhang G, et al. The different metabolism of morusin in various species and its potent inhibition against UDP-glucuronosyltransferase (UGT) and cytochrome p450 (CYP450) enzymes. Xenobiotica. 2016;46:467–476.
   PubMed Web of Science ®Google Scholar
• Zhang YY, Liu Y, Zhang JW, et al. C-7 configuration as one of determinants in taxanes metabolism by human cytochrome P450 enzymes. Xenobiotica. 2009;39:903–914.
   PubMed Web of Science ®Google Scholar
• Naritomi Y, Terashita S, Kimura S, et al. Prediction of human hepatic clearance from in vivo animal experiments and in vitro metabolic studies with liver microsomes from animals and humans. Drug Metab Dispos. 2001;29:1316–1324.
   PubMed Web of Science ®Google Scholar
• Li S, Teng L, Liu W, et al. Interspecies metabolic diversity of harmaline and harmine in in vitro 11 mammalian liver microsomes. Drug Test Anal. 2017;9:754–768.
   PubMed Web of Science ®Google Scholar
• Liu Z, Yang Y, Sheng L, et al. Interspecies variation of in vitro stability and metabolic diversity of YZG-331, a promising sedative-hypnotic compound. Front Pharmacol. 2017;8:527.
   PubMed Web of Science ®Google Scholar
• Bao KD, Li P, Qi LW, et al. Characterization of flavonoid metabolites in rat plasma, urine, and feces after oral administration of Semen Ziziphi Spinosae extract by HPLC-diode-array detection (DAD) and ion-trap mass spectrometry (MS(n)). Chem Pharm Bull (Tokyo). 2009;57:144–148.
   PubMed Web of Science ®Google Scholar
• Shan L, Zhang G, Guo Z, et al. In vitro investigation of permeability and metabolism of licoricidin. Life Sci. 2019;234:116770.
   PubMed Web of Science ®Google Scholar
• Vacek J, Papouskova B, Vrba J, et al. LC-MS metabolic study on quercetin and taxifolin galloyl esters using human hepatocytes as toxicity and biotransformation in vitro cell model. J Pharm Biomed Anal. 2013;86:135–142.
   PubMed Web of Science ®Google Scholar
• Ma XC, Ning J, Ge GB, et al. Comparative metabolism of cinobufagin in liver microsomes from mouse, rat, dog, minipig, monkey, and human. Drug Metab Dispos. 2011;39:675–682.
   PubMed Web of Science ®Google Scholar
• Wang Q, Qiao X, Liu CF, et al. Metabolites identification of glycycoumarin, a major bioactive coumarin from licorice in rats. J Pharm Biomed Anal. 2014;98:287–295.
   PubMed Web of Science ®Google Scholar
• Ma Z, Shi X, Zhang G, et al. Metabolism and metabolic inhibition of xanthotoxol in human liver microsomes. Evid Based Complement Alternat Med. 2016;2016:5416509.
   PubMedGoogle Scholar
• Seibert E, Tracy TS. Different enzyme kinetic models. Methods Mol Biol. 2014;1113:23–35.
   PubMedGoogle Scholar
• Li XQ, Bjorkman A, Andersson TB, et al. Identification of human cytochrome P(450)s that metabolise anti-parasitic drugs and predictions of in vivo drug hepatic clearance from in vitro data. Eur J Clin Pharmacol. 2003;59:429–442.
   PubMed Web of Science ®Google Scholar
• Shimada T, Mimura M, Inoue K, et al. Cytochrome P450-dependent drug oxidation activities in liver microsomes of various animal species including rats, guinea pigs, dogs, monkeys, and humans. Arch Toxicol. 1997;71:401–408.
   PubMed Web of Science ®Google Scholar